BrainCheck Secures $15 Million to Fuel Expansion and Adoption of its Next Generation Digital Cognitive Assessment and Care Planning Platform
New Financing Round, Led By Next Coast Ventures, S3 Ventures, And UPMC Enterprises, Positions Company For Continued Growth, Innovation, And Integration
BrainCheck Expands Board of Directors with Appointment of Nicholas Shapiro as New Board Member, Further Strengthening the Company’s Strategic Leadership
BrainCheck, Inc., a digital health innovator delivering first-of-its-kind technology into the growing digital cognitive assessment market, today announced a $15 million new financing round, led by Next Coast Ventures, S3 Ventures, and UPMC Enterprises, the innovation, commercialization, and venture capital arm of ...
Source: EMR and HIPAA - April 2, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT BrainCheck Health IT Funding Health IT Fundings Health IT Investment Kim Rodriguez Michael Smerklo Next Coast Ventures Nicholas Shapiro S3 Ventures UPMC Enterprises Source Type: blogs
The Long and Tortured History of Alpha-Synuclein and Parkinson ’s Disease
This study tracks the decades-long journey to harness alpha-synuclein as a treatment for Parkinson’s disease. Steven Zecola an activist who tracks Parkinson’s research and was on THCB last month discussing it, offers three key changes needed to overcome the underlying challenges.
A Quick Start for Alpha-Synuclein R&D
In the mid-1990’s, Parkinson’s patient advocacy groups had become impatient by the absence of any major therapeutic advances in the 25 years since L-dopa had been approved for Parkinson’s disease (PD).
The Director of National Institute of Neurological Disorders and Stroke (NINDS) se...
Source: The Health Care Blog - March 29, 2024 Category: Consumer Health News Authors: matthew holt Tags: Health Policy Medical Practice Parkinson's Disease Steven Zecola Source Type: blogs
A Lengthy View of Everything that is Wrong with the Drug Development Industry
The primary problems with drug development are self-evident from the data. Firstly the process of drug development has become enormously more expensive over the past seventy years, a period in in which rapid technological progress has diminished the cost and effort required for any task in pharmacology and biotechnology by orders of magnitude. Secondly, the pace at which useful new medicines emerge in the clinic has diminished considerably, over the same period of technological progress in which the bounds of the possible have opened up enormously. The article I'll point out today is well worth reading, a lengthy treatment...
Source: Fight Aging! - March 12, 2024 Category: Research Authors: Reason Tags: Politics and Legislation Source Type: blogs
HealthSnap Closes $25 Million Series B Funding Amidst Continued Triple Digit Growth of Remote Patient Monitoring and Chronic Care Management Platform
New Investment is Led by Sands Capital, with Participation from Comcast Ventures, and Follows Enterprise Health System Expansions
HealthSnap, a Miami-based Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) solution for healthcare providers, today announced its Series B financing totaling $25 million. The round was led by Sands Capital, with new investments from Comcast Ventures, Acronym Venture Capital, and Florida Opportunity Fund. Existing shareholders, Asclepius Growth Capital, Florida Funders, MacDonald Ventures, and TGH Ventures also participated in the round. Scott Frederick, a Managing Partner at...
Source: EMR and HIPAA - March 7, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Acronym Venture Capital Angela Orsky Asclepius Growth Capital Comcast Ventures Florida Funders Florida Opportunity Fund Health IT Funding Health IT Fundings Health IT Investment HealthSnap MacDonald Source Type: blogs
First Analysis Invests in Dina, Provider of Home-Centered Care Coordination Solutions
Digital Network Management and Coordination Solutions to Help Health Plans and Providers Improve Access to Home Centric Care
First Analysis, a leading venture capital investor, has made a new investment in Dina, a provider of digital network management and coordination solutions for the Medicare Advantage and Managed Medicaid markets, with a focus on coordinating supplemental benefits and long-term services and supports (LTSS).
First Analysis led the $7 million Series B round, with participation from existing investors Osage Venture Partners and First Trust Capital Partners, LLC.
In December, SCAN Group, a mission-driven o...
Source: EMR and HIPAA - March 7, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Andrew Walsh Ashish V. Shah Corey Greendale dina First Analysis First Trust Capital Partners Health IT Funding Health IT Fundings Health IT Investment Osage Venture Partners SCAN Group Source Type: blogs
Fight Aging! Newsletter, March 4th 2024
In conclusion, HSV (but not CMV) infection may be indicative of doubled dementia risk.
« Back to Top
Increased Dietary Leucine Activates mTOR Signaling in Macrophages, Accelerating Atherosclerosis
https://www.fightaging.org/archives/2024/02/increased-dietary-leucine-activates-mtor-signaling-in-macrophages-accelerating-atherosclerosis/
Leucine is an essential amino acid, only obtained from the diet rather than synthesized by our cells. Leucine supplementation has been proposed as a way to slow the loss of muscle mass with age, as leucine processing becomes dysregulated with aging in a way...
Source: Fight Aging! - March 3, 2024 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology
Using Novel Digital Twins of Clinical Trial Participants, Unlearn is Accelerating Clinical Research to Help Bring New Treatments to Patients Sooner
Unlearn, an AI company creating digital twins of clinical trial participants that enable smaller, faster studies, today announced a $50M Series C round led by Altimeter Capital, joined by returning investors Radical Ventures, Wittington Ventures, Mubadala Capital, Epic Ventures, and Necessary Venture Capital. This round of funding was secured to propel the company’s mission to advance AI to eliminate trial and error in medicine by investing in its people, data, engineering ca...
Source: EMR and HIPAA - February 29, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT 8VC Altimeter Capital Charles Fisher DCVC DCVC Bio Epic Ventures Health IT Funding Health IT Fundings Health IT Investment Insight Partners Mubadala Capital Necessary Venture Capital Pauline Yang Source Type: blogs
Why Don't Biotech Investors Run Replication Studies Before Investing?
Ichor Life Sciences is one of the earliest longevity industry companies, an interesting mix of contract research organization (CRO), biotech working on several different therapeutics, and investor in very early stage biotech startups. One of the Ichor co-founders here offers an interesting, though possibly biased perspective on how investors should behave in the biotech space. Inside companies, every new development program in the biotech industry starts with an attempt to replicate the research results that form the basis for the program, even given the existence of detailed, published papers and a coven of accessible res...
Source: Fight Aging! - February 28, 2024 Category: Research Authors: Reason Tags: Longevity Industry Source Type: blogs
Digital Health, Menopause, And The $150 Billion Ignorance
The idea of this story came from personal experience. During the past year, I have spent countless hours and a bucketload of money trying to figure out what the heck is wrong with my health. I was feeling worse and worse, having various symptoms, totally inexplicable with my impeccable test results. During this journey, not a single doctor asked or suggested that my symptoms may come from entering perimenopause – the stage of life of women preceding menopause.
I am 47 years old, and as I have learned since then, extremely average in starting to have perimenopause symptoms at the age of 47. Also very average ...
Source: The Medical Futurist - February 22, 2024 Category: Information Technology Authors: Andrea Koncz Tags: TMF Lifestyle medicine female health menopause tech Source Type: blogs
Austin-Based Vital Interaction Closes $15M Series A Funding Round to Revamp Patient Communication with Hyper-Personalization
Vital Interaction, a healthcare technology company that combines healthcare data, business intelligence, and workflow automation, today announced the closing of $15 million in Series A funding led by Austin-based Next Coast Ventures. Vital Interaction uses key practice and patient data to ensure patients follow through on prescribed care plans, recalling and reactivating both new and existing patients to encourage follow-up appointments and reduce patient churn. It uses appointment, clinical, and billing data to generate automated, customizable campaigns for targeted patient outreach.
By analyzing millions of these patient...
Source: EMR and HIPAA - February 19, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Ben Chapman Health IT Funding Health IT Fundings Health IT Investment Michael Smerklo Next Coast Ventures Vital Interaction Source Type: blogs
The Optimism of Digital Health
By JONATHON FEIT
Journalists like being salty. Like many venture investors, we who are no longer “green” have finely tuned BS meters that like to rip off the sheen of a press release to reach the truthiness underneath. We ask, is this thing real? If I write about XYZ, will I be embarrassed next year to learn that it was the next Theranos?
Yet journalists must also be optimistic—a delicate balance: not so jaded that one becomes boooring, not so optimistic that one gets giddy at each flash of potential; and still enamored of the belief that every so often, something great will remake the present paradigm.
T...
Source: The Health Care Blog - February 9, 2024 Category: Consumer Health News Authors: matthew holt Tags: Health Tech AI DHIS West Jonathon Feit Michelle Snyder venture capital Source Type: blogs
An Interview with Karl Pfleger
Karl Pfleger is one of the more prolific angel investors in the longevity industry. Naturally he is an investor in Repair Biotechnologies, the company that I co-founded with Bill Cherman and which is currently focused on a gene therapy approach to reversal of atherosclerosis. In addition to his investment and conference-going activities, Pfleger runs the very useful Aging Biotech Info resource, which has expanded from the starting point of a list of companies in the longevity industry to its present state of listing of a great many more items: conferences, books, blogs, interventions, diagnostics, and so forth. In the podc...
Source: Fight Aging! - February 5, 2024 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs
Credo Health Announces Oversubscribed $5.25 Million Series Seed Funding
Credo Health, a leader in technology for value-based care, has successfully secured $5.25 million in series seed funding. FCA Venture Partners led the round with existing investors that include Hannah Grey VC, FirstMile Ventures, and SpringTime Ventures.
Credo Health is the only company that combines both digital and manual medical record retrieval with AI-driven analysis and human expertise to ensure providers have the complete clinical picture of every patient.
This substantial investment reinforces Credo Health’s mission to build the definitive platform for value-based care providers. Its core platform, PreDx, provide...
Source: EMR and HIPAA - February 1, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Carm Huntress Credo Health FCA Venture Partners FirstMile Ventures Hannah Grey VC Health IT Funding Health IT Fundings Health IT Investment SpringTime Ventures Tom Hearn Vim Source Type: blogs
Care Continuity Secures $10M in Funding to Fuel Growth in Patient Navigation
Today, Care Continuity, a leader in data-driven patient navigation serving some of the country’s largest health systems, payers, and ACOs, announced the close of $10 million in Series A-3 funding co-led by Empactful Capital and Viewside Capital Partners with participation from Flat Creek Capital and Loop 289 Limited Partners.
The funding will enable Care Continuity to further its mission of helping health systems, payers and ACOs employ an efficient patient and member-centered care journey, as well as make strategic investments in growth, product development, and further enablement of AI to enhance Care Continuity...
Source: EMR and HIPAA - January 29, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Brad Prugh Care Continuity Empactful Capital Flat Creek Capital Health IT Funding Health IT Fundings Health IT Investment Loop 289 Limited Partners Sal DeTrane Viewside Capital Partners Source Type: blogs
XRHealth Secures $6 Million in Funding Led by Asabys Partners and Welcomes NOVA Prime as a New Investor
Funding will Support Development of AI Clinician, Using Spatial Computing
XRHealth, the leading healthcare platform in Spatial computing, announced today that the company secured $6 million in funding led by Asabys Partners, with the participation of NOVA Prime Fund, a venture capital fund created by global innovator LG Electronics and Clearbrook, LLC., and XRHealth’s current investors. Marking the completion of the merger between XRHealth and Amelia Virtual Care, the funding supports the growth of the combined entities. The funding will also further the development of an AI-based clinician that can treat patients for m...
Source: EMR and HIPAA - January 19, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Ali Diallo Amelia Virtual Care Asabys Partners Clearbrook LLC. Eran Orr Health IT Funding Health IT Fundings Health IT Investment LG Electronics NOVA Prime Fund XRHealth Source Type: blogs
